Press release
Cancer Therapeutics Market: Advancements in Drug Development and Demand Surge - Major Companies are F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie Inc.
Cancer Therapeutics Market reached US$ 168.15 billion in 2024 and is expected to reach US$ 491.60 billion by 2032, growing at a CAGR of 12.6% during the forecast period 2025-2032.Cancer Therapeutics market holds a leading position in the industry and is thoroughly examined in the DataM Intelligence study, which provides a comprehensive analysis supported by robust statistics, historical data, and actionable insights. The report evaluates key industry players by analyzing their product portfolios, pricing strategies, financial performance, and expansion initiatives. It offers a clear understanding of market dynamics, competitive positioning, and the emerging trends shaping the industry's future.
Get a Premium Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cancer-therapeutics-market?rk
Rising Global Cancer Incidence Fueling Therapeutics Demand
The growing global incidence of cancer is a major factor propelling the expansion of the cancer therapeutics market. As cancer cases continue to rise, so does the demand for effective treatment options. According to 2024 projections from the World Health Organization, cancer cases are expected to surpass 35 million by 2050-marking a 77% increase from approximately 20 million cases reported in 2022.
In the U.S., the American Cancer Society reported that as of January 1, 2022, over 18 million Americans (8.3 million men and 9.7 million women) were living with a history of cancer. This rising burden has driven heightened investment in research and development of new therapeutic approaches. Increased public awareness and improved professional understanding of cancer treatments are also prompting earlier diagnosis and intervention. Additionally, government programs promoting early screening and expanding healthcare access are contributing to the growing demand for cancer therapeutics, reinforcing the market's upward trajectory.
Impact of Generic Drug Availability on Market Growth
Despite market growth, the rising availability of generic drugs poses a challenge to the cancer therapeutics industry. While generics improve affordability and access for patients, their presence can lead to significant revenue losses for companies that develop branded, innovative treatments. The entry of generics creates intense price competition, often compelling originator companies to lower their prices. This competitive pressure can limit the profitability of research-driven pharmaceutical firms and may hinder further investment in novel drug development.
Leading Companies Operating in the Cancer Therapeutics Market:
F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie Inc., Astellas Pharma Inc., Pfizer, Inc., Novartis AG, Merck & Co., Inc., Eli Lilly and Company, Amgen Inc. and AstraZeneca and Pfizer Inc. among others.
Research Process:
Our research methodology combines both qualitative and quantitative approaches to provide you with a thorough market analysis. We begin by gathering data from trusted industry reports and databases (secondary research), followed by primary research through surveys and interviews with key experts. We then apply advanced statistical tools to analyze the data, uncover trends, and assess market dynamics. Additionally, we use market segmentation and Porter's Five Forces analysis to evaluate competition. This approach ensures that the insights we provide are reliable, actionable, and tailored to support your decision-making process.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-therapeutics-market
Segment Covered in the Cancer Therapeutics Market:
By Therapy: Targeted Therapy, Hormonal Therapy, Chemotherapy, Radiotherapy, Immunotherapy, Others (Photodynamic Therapy, Others)
By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, Cervical Cancer, Malignant Meningioma, Head and Neck Cancer, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By End-User: Hospitals, Cancer Centers, Research Institutes
Regional Analysis for Cancer Therapeutics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Cancer Therapeutics Industry Development:
In January 2023, Loxo@Lilly received FDA approval for Jaypirca (pirtobrutinib, available in 100 mg and 50 mg tablets) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have previously undergone at least two lines of systemic therapy, including a Bruton's tyrosine kinase (BTK) inhibitor.
In May 2024, Amgen Inc. was granted accelerated approval by the FDA for tarlatamab-dlle to treat extensive-stage small cell lung cancer (ES-SCLC) in patients whose disease has progressed following platinum-based chemotherapy.
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Cancer Therapeutics market?
➠ Who are the global key manufacturers of the Cancer Therapeutics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Cancer Therapeutics market opportunities and threats faced by the vendors in the global Cancer Therapeutics Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Cancer Therapeutics market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Therapeutics Market: Advancements in Drug Development and Demand Surge - Major Companies are F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie Inc. here
News-ID: 4035723 • Views: …
More Releases from DataM Intelligence 4market Research LLP

Water Treatment Equipment Market: Regional Insights and Competitive Landscape - …
The Global Water Treatment Equipment Market is expected to grow at a significant CAGR of 6.7% during the forecasting period (2024-2031).
Water Treatment Equipment market holds a leading position in the industry and is thoroughly examined in the DataM Intelligence study, which provides a comprehensive analysis supported by robust statistics, historical data, and actionable insights. The report evaluates key industry players by analyzing their product portfolios, pricing strategies, financial performance, and…

Nano-Biotechnology Market reached US$ 137.3 billion in 2024 and is expected to r …
Nano-Biotechnology Market reached US$ 137.3 billion in 2024 and is expected to reach US$ 270.56 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033.
Nano-Biotechnology market holds a leading position in the industry and is thoroughly examined in the DataM Intelligence study, which provides a comprehensive analysis supported by robust statistics, historical data, and actionable insights. The report evaluates key industry players by analyzing their product…

AI in Telecommunications: Driving Smarter Customer Experiences and Network Effic …
Global AI in Telecommunication Market reached US$ 2.63 billion in 2024 and is expected to reach US$ 35.69 billion by 2032, growing with a CAGR of 38.54% during the forecast period 2025-2032.
AI in Telecommunication market holds a leading position in the industry and is thoroughly examined in the DataM Intelligence study, which provides a comprehensive analysis supported by robust statistics, historical data, and actionable insights. The report evaluates key…

Generative AI Fuels Automotive Advancements in Safety and Efficiency - Leading C …
Gen AI in Automotive Market reached US$ 514.50 million in 2024 and is expected to reach US$ 2,609.00 million by 2032, growing with a CAGR of 22.50% during the forecast period 2025-2032.
Gen AI in Automotive market holds a leading position in the industry and is thoroughly examined in the DataM Intelligence study, which provides a comprehensive analysis supported by robust statistics, historical data, and actionable insights. The report evaluates…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…